Our results in this new study confirm in LCLs from four different FA‐A patients the feasibility of conducting gene editing, even with a non‐therapeutic donor that only carries a reporter EGFP transgene, demonstrating for the first time that FANCA is not essential for the HDR‐mediated editing of the human genome. The gene discussed is FANCA; the disease is Fanconi anemia complementation group A.